Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Prevalence of CRE Colonization in Hematopoietic Cell Transplant Recipients and Its Impact on Clinical Outcomes: Experience From a Developing Country

CT - 691

Prevalence of CRE Colonization in Hematopoietic Cell Transplant Recipients and Its Impact on Clinical Outcomes: Experience From a Developing Country

Zahid Khan Zada

Poster Presenter: Zahid Khan Zada

Thumbnail for Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

CML - 692

Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

Ehab L Atallah

Poster Presenter: Ehab L Atallah

Previous 1...52 53 54 55 56 57 58...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

CLL - 693

BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

Ekow Pinkrah

Poster Presenter: Ekow Pinkrah

Thumbnail for Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CML - 694

Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Akriti G Jain

Poster Presenter: Akriti G Jain

Thumbnail for Social Isolation and Loneliness in Hematologic Malignancies: A National Inpatient Sample Analysis 2017-2022

MDS - 695

Social Isolation and Loneliness in Hematologic Malignancies: A National Inpatient Sample Analysis 2017-2022

Preetham Ezhilarasu

Poster Presenter: Preetham Ezhilarasu

Thumbnail for Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

MPN - 696

Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for DLBCL AdaptIQ: A Molecular-Adaptive Clinical Decision Support System for Personalized Regimen Selection and Real-Time Clinical Trial Matching: Development and Dataset Validation in Diffuse Large B-Cell Lymphoma

ABCL - 697

DLBCL AdaptIQ: A Molecular-Adaptive Clinical Decision Support System for Personalized Regimen Selection and Real-Time Clinical Trial Matching: Development and Dataset Validation in Diffuse Large B-Cell Lymphoma

Leena Alhusari

Poster Presenter: Leena Alhusari

Thumbnail for Excess Mortality in Myelodysplastic Neoplasms With Ring Sideroblasts Compared With the Spanish General Population a GESMD Registry Study

MDS - 700

Excess Mortality in Myelodysplastic Neoplasms With Ring Sideroblasts Compared With the Spanish General Population a GESMD Registry Study

Pina Gabriela G?lvez Zavala

Poster Presenter: Pina Gabriela G?lvez Zavala

Thumbnail for Lower Neighborhood Income Independently Predicts Reduced Inpatient Chemotherapy Utilization in Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2017-2022

AML - 701

Lower Neighborhood Income Independently Predicts Reduced Inpatient Chemotherapy Utilization in Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2017-2022

Preetham Ezhilarasu

Poster Presenter: Preetham Ezhilarasu

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors